KUALA LUMPUR: YSP Southeast Asia Holding Bhd, a pharmaceutical, healthcare and veterinary specialist, will ride on the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTTP) trade agreement signed recently to expand overseas. YSP president and group managing director Datuk Dr Lee Fang Hsin said the company aimed to expand its pharmaceutical and healthcare business and the CPTTP would be helpful as it listed out markets that promoted trade and investment flows. The domestic pharmaceutical, healthcare and veterinary market contributes 65 to 70 per cent to the company’s earnings. Lee said while the company was looking at overseas expansion, the focus would still be on growing its business at home. He said the pharmaceutical industry in Malaysia was growing and worth more than US$2 billion (RM7.8 billion), half of which was generated by local pharmaceutical players.

Source: New Strait Times March 25, 2018 21:11 UTC